Abstracts Archive - Page 182 of 1683 - ATC Abstracts

2022 American Transplant Congress
Living Related Kidney Donation for Alport Syndrome Spectrum: Long-Term Outcomes
Y. Caliskan¹, A. B. Dirim², S. Safak², B. Yelken³, A. Velioglu⁴, A. Yildiz⁵, O. A. Oto², N. Guller², H. Yazici², A. Ersoy⁵, A. Turkmen³, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Istanbul University, Istanbul, Turkey, ³Koc University Hospital, Istanbul, Turkey, ⁴Marmara University, Istanbul, Turkey, ⁵Uludag University, Bursa, Turkey
*Purpose: Data to guide the evaluation of living related donor (LRD) candidates for kidney transplant recipients with Alport syndrome (AS) spectrum are limited. We examined…
2022 American Transplant Congress
Inhibition of ITGB5 Protects Hepatocytes from Ischemia Reperfusion Injury
M. Dogan¹, S. Naik¹, C. Watkins¹, A. Bajwa¹, V. Mas², J. Eason³, C. Kuscu¹, C. Kuscu¹
¹Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, ²Surgery, University of Maryland, Baltimore, MD, ³University of Tennessee/Methodist Transplant Institute, Memphis, TN
*Purpose: Liver transplantation is the best treatment option for patients with end-stage liver disease (ESLD). Despite the increasing interest to the machine reperfusion, cold preservation…
2022 American Transplant Congress
Deletion of AIF-1 Promotes Kidney Reparative Macrophages and Prevents Fibrosis
I. Husain, A. Dangi, X. Luo
Duke University School of Medicine, Durham, NC
*Purpose: A major etiology contributing to poor allograft survival is the inevitable ischemic insult it incurs during transplantation. Macrophages are key players in ischemia-reperfusion injury,…
2022 American Transplant Congress
Alloimmunization Against Red Blood Cell Antigens is Not Associated with Increased All Cause Mortality in Liver Transplant Recipients
Y. Chornenkyy¹, A. P. Gama¹, N. Khurram¹, A. L. Booth¹, J. R. Leventhal², G. E. Ramsey¹, G. Yang¹
¹Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: Liver transplantation (LT) is a life‐saving procedure for patients with end‐stage liver disease and transfusion therapy of LT patients remains a challenge. Improvement of…
2022 American Transplant Congress
Normothermic Organ Preservation: The New Standard?
K. Mistry
Sanford Health, Fargo, ND
*Purpose: Normothermic perfusion (NMP) is a new technique that has been introduced into transplantation expanding capacity for organ utilization. NMP has been shown to be…
2022 American Transplant Congress
Evolution of the Need for Transplant Evaluations for Liver Failure Decompensation After TIPS
N. Kemmer¹, V. Sureshkumar², L. Grater³, G. Hoots⁴, S. Agrawal¹, K. Robichaux⁵, M. Gosselin³, S. Mohammed⁵, A. Kumar⁶, J. Buggs⁷
¹Transplant Hepatology, Tampa General Hospital, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³University of Tampa, Tampa, FL, ⁴Radiology, Tampa General Hospital, Tampa, FL, ⁵University of South Florida, Tampa, FL, ⁶Morsani College of Medicine, University of South Florida, Tampa, FL, ⁷Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Portal hypertension is described as an increased pressure gradient between the portal and systemic circulation which can result in severe complications. Transjugular Intrahepatic Portosystemic…
2022 American Transplant Congress
The Role of Advanced Practice Providers in Liver Transplant Centers
S. Nargiso, L. Sher, V. Tristan
Keck Medical Center at University of Southern California, Los Angeles, CA
*Purpose: Care for the liver transplant (LT) recipient requires expertise and consistency. Due to the rotation of trainees and the emphasis on surgical experience for…
2022 American Transplant Congress
The Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals
R. Gruessner, J. Renz, A. C. Gruessner
Medicine, SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver transplants (DDLT) that have achieved or came close to 100 years of function first in the donor…
2022 American Transplant Congress
Analysis and Outcomes of Liver Re Transplantation After Initial DCD Liver Transplantation
A. Kadimella¹, J. Eason², R. Helmick², J. Vanatta²
¹HPB and Liver Transplantation, AIG Hospitals, Hyderabad, India, ²University of Tennessee/Methodist Transplant Institute, Memphis, TN
*Purpose: DCD livers were more prone for ischemic cholangiopathy and graft failure than DBD livers due to multi factorial reasons. With all the available data…
2022 American Transplant Congress
Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients
W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han
Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of
*Purpose: The use of immunosuppressive agents, especially glucocorticoids, are associated with increased risks of bone loss in kidney transplant recipients (KTRs). Denosumab, a potent antiresorptive…